MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation. With a focus on R&D, production and sales of DNA sequencing instruments, reagents, and related products, MGI provides real-time, panoramic, and full-life-cycle equipment and systems for precision medicine, precision healthcare and other
relevant areas. MGI is a leading producer of clinical high-throughput
gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation.
VarSome was created by Swiss precision medicine company Saphetor SA. The platform is relied upon by researchers and clinicians from around the world, and has been referenced in over 2 000 peer-reviewed papers, to help them interpreted human genome data produced by next generation sequencing platforms such as the MGI ﬂeet of sequencers. VarSome maintains, harmonizes, and integrates over 140 genomic databases and over 32 million publications to provide the most comprehensive variant interpretation engine there is.
VarSome Clinical, is a CE IVD-certiﬁed software that can work with MGI FASTQ and VCF ﬁles to fully annotate samples by using proprietary ACMG, AMP, and CNV classiﬁers applying industry standard variant interpretation guidelines across
the VarSome database to quickly identify variants of interest, present evidence, and generate reports.